Skip to content
Explore the UK's finest traditions, modern trends, and hidd…

Individuals Coming Off Weight-Loss Medications Put On Pounds Far More Rapidly Than Those on Conventional Diets

Illustration of medical injection and scale
Weight management often requires ongoing approaches.

Fresh analysis suggests that patients who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt conventional lifestyle programs.

Findings released in a major medical journal demonstrates that while obese people can lose a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"People buying such medications should be aware of the potential of fast rebound weight gain when the medication ends," warns expert Dr. Susan Jebb.

That rate of recovery suggests a return to starting weight within about 18 months.

Comparing Approaches

The research, which looked at dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.

Scientists point out that people who shed pounds through dieting typically have a less rapid weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Experts suggest the mechanism of the injections accounts for the amplified rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which moderates hunger.

"Artificially providing the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating far more likely."

An Ongoing Condition?

Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

Many experts say that, due to the significant potential of relapse, the treatment should be considered life-long.

This view is reinforced by pharmaceutical companies, who note that the findings "underscore the long-term character of obesity," similar to managing conditions like hypertension.

User Accounts

Users who have come off the jabs describe a powerful resurgence of hunger.

"I experienced a switch that goes on and you're instantly ravenous," described one woman.

The struggle is compounded if users have not developed sustainable dietary or behavioural changes during therapy.

Widespread Adoption

Figures indicate that millions of adults in the UK have used these injections in the past year, with desire continuing to grow.

  • Adoption is greater among females compared to men.
  • The middle-aged demographic shows the greatest usage rates.
  • Many access the drugs through private healthcare rather than public health services.

Ultimately, researchers caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic fix and lasting health benefits likely depends on combined behavioural support.

The writer

Austin Francis

Eleanor Whitmore is a British travel writer and cultural enthusiast with a decade of experience exploring the UK's finest offerings.

Brit Guide

Type to search articles.